8-19965299-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000237.3(LPL):c.1428-11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0987 in 780,010 control chromosomes in the GnomAD database, including 4,054 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.094 ( 660 hom., cov: 32)
Exomes 𝑓: 0.10 ( 3394 hom. )
Consequence
LPL
NM_000237.3 intron
NM_000237.3 intron
Scores
2
Splicing: ADA: 0.00003292
2
Clinical Significance
Conservation
PhyloP100: -0.151
Publications
28 publications found
Genes affected
LPL (HGNC:6677): (lipoprotein lipase) LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq, Jul 2008]
LPL Gene-Disease associations (from GenCC):
- familial lipoprotein lipase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- hyperlipidemia, familial combined, LPL relatedInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 8-19965299-C-T is Benign according to our data. Variant chr8-19965299-C-T is described in ClinVar as Benign. ClinVar VariationId is 1269038.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LPL | NM_000237.3 | c.1428-11C>T | intron_variant | Intron 9 of 9 | ENST00000650287.1 | NP_000228.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LPL | ENST00000650287.1 | c.1428-11C>T | intron_variant | Intron 9 of 9 | NM_000237.3 | ENSP00000497642.1 | ||||
| LPL | ENST00000650478.1 | n.*251-11C>T | intron_variant | Intron 3 of 3 | ENSP00000497560.1 |
Frequencies
GnomAD3 genomes AF: 0.0942 AC: 14328AN: 152036Hom.: 661 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
14328
AN:
152036
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0954 AC: 23944AN: 250918 AF XY: 0.0971 show subpopulations
GnomAD2 exomes
AF:
AC:
23944
AN:
250918
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0999 AC: 62700AN: 627856Hom.: 3394 Cov.: 0 AF XY: 0.101 AC XY: 34510AN XY: 342038 show subpopulations
GnomAD4 exome
AF:
AC:
62700
AN:
627856
Hom.:
Cov.:
0
AF XY:
AC XY:
34510
AN XY:
342038
show subpopulations
African (AFR)
AF:
AC:
1261
AN:
17666
American (AMR)
AF:
AC:
2665
AN:
43624
Ashkenazi Jewish (ASJ)
AF:
AC:
2309
AN:
20936
East Asian (EAS)
AF:
AC:
4424
AN:
36032
South Asian (SAS)
AF:
AC:
6532
AN:
69642
European-Finnish (FIN)
AF:
AC:
4805
AN:
53078
Middle Eastern (MID)
AF:
AC:
404
AN:
4144
European-Non Finnish (NFE)
AF:
AC:
37161
AN:
349680
Other (OTH)
AF:
AC:
3139
AN:
33054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2554
5107
7661
10214
12768
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0941 AC: 14316AN: 152154Hom.: 660 Cov.: 32 AF XY: 0.0933 AC XY: 6937AN XY: 74376 show subpopulations
GnomAD4 genome
AF:
AC:
14316
AN:
152154
Hom.:
Cov.:
32
AF XY:
AC XY:
6937
AN XY:
74376
show subpopulations
African (AFR)
AF:
AC:
2964
AN:
41524
American (AMR)
AF:
AC:
1278
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
380
AN:
3472
East Asian (EAS)
AF:
AC:
561
AN:
5168
South Asian (SAS)
AF:
AC:
464
AN:
4814
European-Finnish (FIN)
AF:
AC:
976
AN:
10592
Middle Eastern (MID)
AF:
AC:
30
AN:
292
European-Non Finnish (NFE)
AF:
AC:
7327
AN:
67980
Other (OTH)
AF:
AC:
195
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
677
1354
2032
2709
3386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
367
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.